Skip to Main Content

Paper Details

Fatal, ischemic and bleeding risk of patients meeting the selection criteria of the TWILIGHT trial: Insights from a large PCI registry.
0
2023
MI, Patients, ST-segment elevation myocardial infarction, aspirin, cardiogenic shock, patients, stroke, thrombocytopenia, ticagrelor
Author NameAffiliation
Samantha SartoriZena and Michael A. Wiener Cardiovascular Institute Icahn School of Medicine at Mount Sinai New York NY.
Usman BaberUniversity of Oklahoma Health Sciences Center
Roxana MehranZena and Michael A. Wiener Cardiovascular Institute Icahn School of Medicine at Mount Sinai New York NY. Electronic address: .
  • 1 - 3

Datasets